An extraction-free kit enables gene expression analysis directly from hepatocyte lysates, delivering results in 75 minutes with sensitivity comparable to RNA purification.

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a definitive ...

Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs. Under deal ...

The business, which provides filters for the purification of food or beverages and drugs during development, brought in about $1 billion in revenue in 2024, Thermo said. Evercore analyst Vijay Kumar ...

On Tuesday, Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to acquire Solventum’s (NYSE:SOLV) Purification & Filtration business for approximately $4.1 billion in cash. Solventum’s Purification & ...